ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1069

Non-Receptor Protein Tyrosine Phosphatase 14 (PTPN14) Promotes YAP-Dependent Tgfbeta Signaling in RA FLS

Angel Bottini1, Dennis J. Wu2, Rizi Ai3, Michelle LeRoux4, Beatrix Bartok1, Michele Bombardieri5, Vida Zhang6, Karen M. Doody7, Cristiano Sacchetti1, Martina Zoccheddu1, Ana Lonic8, David L. Boyle9, Deepa Hammaker9, Tzu-Ching Meng10, Maripat Corr3, Stephanie M. Stanford3, Myles J. Lewis11, Wei Wang12, Gary S. Firestein9, Yeesim Khew-Goodall8, Costantino Pitzalis13 and Nunzio Bottini14, 1Rheumatology, University of California San Diego, La Jolla, CA, 2University of California San Diego, San Diego, CA, 3University of California San Diego, La Jolla, CA, 4La Jolla Institute for Allergy and Immunology, LA JOLLA, CA, 5Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, United Kindgdom, London, United Kingdom, 6La Jolla Institute for Allergy and Immunology, La Jolla, CA, 7Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 8SA Pathology and University of South Australia, Adelaide, Australia, 9Medicine, University of California San Diego, La Jolla, CA, 10Academia Sinica, Taipei, Taiwan, 11Barts Health NHS Trust & Barts and the London School of Medicine & Dentistry, London, United Kingdom, London, United Kingdom, 12Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 13Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 14Medicine/Rheumatology, University of California San Diego, La Jolla, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Session Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Non-Receptor Protein Tyrosine Phosphatase 14 (PTPN14) was identified in a phosphatase expression profile survey to be highly expressed in synovial fibroblasts derived from patients with rheumatoid arthritis (RA FLS). PTPN14 is a negative regulator of transcriptional co-activator YAP -a key Hippo pathway player- in cancer cells. Here we aimed to investigate the role of PTPN14 in RA FLS.

Methods:

Gene expression level in RA FLS and FLS from osteoarthritis patients (OA FLS) was measured by qPCR. Specific gene knockdown was achieved using antisense oligonucleotides. PTPN14, YAP and SMAD3 protein expression levels were visualized in Western blotting and immunofluorescence. Immunoprecipitation was used to detect protein-protein interaction. The passive K/BxN arthritis and RA FLS/cartilage co-implantation models were used to assess effects of chemical inhibition of YAP.

Results:

RA FLS displayed TGFbeta-dependent overexpression of PTPN14 compared to OA FLS (p < 0.01). PTPN14 knockdown in RA FLS impaired TGFbeta-dependent expression of matrix metalloproteinase 13 (p < 0.05) and potentiation of inflammatory cytokine signaling. In RA FLS, PTPN14 forms a complex with YAP, promoting TGFbeta-dependent YAP and SMAD3 nuclear localizations. Chemical inhibition of YAP inhibited RA FLS pathogenic behavior and ameliorated arthritis severity in vivo (p < 0.0001).

Conclusion:

In RA FLS, TGFbeta-dependent PTPN14 overexpression acts as a positive feedback TGFbeta-signaling regulator. Surprisingly, in RA FLS PTPN14 enhances nuclear YAP-mediated promotion of SMAD signaling. YAP promotes a wide range of RA FLS pathogenic behaviors, pointing to the Hippo pathway as a potential important regulator of RA FLS and a player in RA pathogenesis.


Disclosure: A. Bottini, None; D. J. Wu, None; R. Ai, None; M. LeRoux, None; B. Bartok, None; M. Bombardieri, None; V. Zhang, None; K. M. Doody, None; C. Sacchetti, None; M. Zoccheddu, None; A. Lonic, None; D. L. Boyle, None; D. Hammaker, None; T. C. Meng, None; M. Corr, None; S. M. Stanford, None; M. J. Lewis, None; W. Wang, None; G. S. Firestein, None; Y. Khew-Goodall, None; C. Pitzalis, None; N. Bottini, Roche, 2,Eli Lilly and Co., 2,Kyowa Kirin Pharmaceutical Research, Inc., 2.

To cite this abstract in AMA style:

Bottini A, Wu DJ, Ai R, LeRoux M, Bartok B, Bombardieri M, Zhang V, Doody KM, Sacchetti C, Zoccheddu M, Lonic A, Boyle DL, Hammaker D, Meng TC, Corr M, Stanford SM, Lewis MJ, Wang W, Firestein GS, Khew-Goodall Y, Pitzalis C, Bottini N. Non-Receptor Protein Tyrosine Phosphatase 14 (PTPN14) Promotes YAP-Dependent Tgfbeta Signaling in RA FLS [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/non-receptor-protein-tyrosine-phosphatase-14-ptpn14-promotes-yap-dependent-tgfbeta-signaling-in-ra-fls/. Accessed January 27, 2023.
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/non-receptor-protein-tyrosine-phosphatase-14-ptpn14-promotes-yap-dependent-tgfbeta-signaling-in-ra-fls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences